MUDr. Beata Dupejova, neurologicka ambulancia, s.r.o.

Banská Bystrica 974 04

3 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Dementia-related Psychosis, Early Parkinson Disease, Idiopathic Parkinson's Disease, Migraine, Multiple Sclerosis, Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy, Psychosis Associated With Alzheimer's Disease, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) — Recruiting now
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) — Recruiting now
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) — Recruiting now
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• Cenobamate Open-Label Extension Study for YKP3089C025 — Completed
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 — Stopped early
• A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis — Completed
• MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist — Completed